Stockscreener 앱 받기
238.65
0.82%
2.1578
전일 마감가:
$236.49
열려 있는:
$235.3
하루 거래량:
237.32K
Relative Volume:
0.20
시가총액:
$36.73B
수익:
$2.75B
순이익/손실:
$714.14M
주가수익비율:
55.11
EPS:
4.33
순현금흐름:
$1.09B
1주 성능:
+5.60%
1개월 성능:
+11.58%
6개월 성능:
+12.12%
1년 성능:
+17.19%
1일 변동 폭
$234.75
$238.52
1주일 범위
$226.51
$238.48
52주 변동 폭
$170.25
$258.93
Veeva Systems Inc Stock (VEEV) Company Profile
명칭
Veeva Systems Inc
전화
925-452-6500
주소
4280 HACIENDA DRIVE, PLEASANTON, CA
VEEV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VEEV
Veeva Systems Inc
|
238.52 | 36.73B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
59.49 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.86 | 9.30B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
92.24 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
41.37 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-23 | 다운그레이드 | Goldman | Buy → Sell |
| 2024-12-20 | 개시 | Stephens | Overweight |
| 2024-12-04 | 개시 | Mizuho | Outperform |
| 2024-11-19 | 개시 | Scotiabank | Sector Perform |
| 2024-10-08 | 개시 | Exane BNP Paribas | Outperform |
| 2024-08-27 | 재확인 | Citigroup | Buy |
| 2024-07-09 | 개시 | BTIG Research | Buy |
| 2023-10-25 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-10-13 | 개시 | Jefferies | Buy |
| 2023-06-28 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-06-01 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-03-17 | 다운그레이드 | Truist | Buy → Hold |
| 2023-02-23 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-01-04 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-12-06 | 개시 | Cowen | Market Perform |
| 2022-12-02 | 재확인 | Needham | Buy |
| 2022-10-31 | 개시 | Wells Fargo | Equal Weight |
| 2022-10-19 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-07-27 | 개시 | Oppenheimer | Outperform |
| 2022-06-23 | 개시 | Goldman | Buy |
| 2022-06-21 | 재개 | Guggenheim | Buy |
| 2022-03-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-01-28 | 개시 | Truist | Buy |
| 2022-01-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-06 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 재개 | Stifel | Buy |
| 2021-09-02 | 재확인 | BofA Securities | Buy |
| 2021-09-02 | 재확인 | JMP Securities | Mkt Outperform |
| 2021-09-02 | 재확인 | Needham | Buy |
| 2021-09-02 | 재확인 | UBS | Neutral |
| 2021-07-21 | 개시 | Cowen | Outperform |
| 2021-03-31 | 업그레이드 | UBS | Sell → Neutral |
| 2021-01-07 | 재개 | KeyBanc Capital Markets | Overweight |
| 2020-12-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-10-14 | 재개 | UBS | Sell |
| 2020-08-28 | 재확인 | Needham | Buy |
| 2020-07-23 | 개시 | FBN Securities | Outperform |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-06-08 | 개시 | Citigroup | Buy |
| 2020-05-29 | 재확인 | Needham | Buy |
| 2020-04-13 | 개시 | SVB Leerink | Mkt Perform |
| 2020-02-19 | 개시 | Robert W. Baird | Outperform |
| 2020-02-14 | 개시 | Piper Sandler | Overweight |
| 2020-01-13 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-27 | 재확인 | Canaccord Genuity | Hold |
| 2019-09-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-08-28 | 재확인 | Needham | Buy |
| 2019-06-07 | 개시 | Goldman | Neutral |
| 2019-05-30 | 재확인 | BofA/Merrill | Buy |
| 2019-05-30 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2019-05-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-04-17 | 재확인 | Needham | Buy |
| 2019-02-27 | 재확인 | Needham | Buy |
모두보기
Veeva Systems Inc 주식(VEEV)의 최신 뉴스
June 2026 Options Now Available For Veeva Systems (VEEV) - Nasdaq
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors - Yahoo
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know - MSN
Here's How Much $100 Invested In Veeva Systems 10 Years Ago Would Be Worth Today - Benzinga
Veeva Systems (NYSE:VEEV) Unveils Veeva AI To Boost Productivity In Life Sciences - Yahoo Finance
Werner Engelbrecht - AI Business
Veeva Systems (VEEV) Introduces Veeva AI to Enhance Life Science - GuruFocus
Veeva Systems Introduces Veeva AI - Contract Pharma
Announcing Veeva AI | VEEV Stock News - GuruFocus
Announcing Veeva AI - Yahoo Finance
Here's Why You Should Add Veeva Stock to Your Portfolio Now - MSN
Press Release Distribution & PR Platform - ACCESS Newswire
Peering Into Veeva Systems's Recent Short Interest - Benzinga
Veeva (VEEV) Price Target Trimmed by Piper Sandler Amid Industry Challenges | VEEV Stock News - GuruFocus
Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network - Yahoo Finance
Life Science Data Needs an Upgrade: Veeva Has Answers - Fierce Pharma
Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock - MSN
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy? - Yahoo Finance
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next - The Motley Fool
Veeva Systems: Substantially Overvalued As Growth Slows (NYSE:VEEV) - Seeking Alpha
Veeva Systems (NYSE:VEEV) Partners With Flatiron To Enhance Clinical Trial Data Efficiency - Yahoo Finance
Flatiron Health Joins Veeva’s Product Partner Program to Accelerate Oncology Clinical Research - Business Wire
Q4 Earnings Outperformers: Veeva Systems (NYSE:VEEV) And The Rest Of The Vertical Software Stocks - Yahoo Finance
Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Veeva Systems’ chief customer officer sells $265,168 in stock By Investing.com - Investing.com India
Veeva Systems’ chief customer officer sells $265,168 in stock - Investing.com
4 Ways Top Sponsors Build Strong and Sustainable Site Relationships - Veeva
Investors Interested In Veeva Systems Inc.'s (NYSE:VEEV) Earnings - simplywall.st
Improve Safety Outputs, Oversight, and Data Quality with In-house Pharmacovigilance Solution - Veeva
B. Braun Transforms Global Clinical Trial Management for Digital Excellence - Veeva
Veeva (VEEV) Moves 3.7% Higher: Will This Strength Last? - Nasdaq
eClinical Solutions Market Top PlayersMedidata, Veeva Systems, Iqvia Inc., Icon Plc, Signant Health. - openPR.com
ACELYRIN Optimizes the Sponsor-CRO Data Flow with a Centralized Clinical Data Workbench - Veeva
Veeva Systems director Timothy Cabral sells $841,734 in stock By Investing.com - Investing.com Canada
Veeva Systems director Timothy Cabral sells $841,734 in stock - Investing.com
Veeva Systems (VEEV) Gains As Market Dips: What You Should Know - Yahoo Finance
Why Is Veeva (VEEV) Down 6.2% Since Last Earnings Report? - Yahoo Finance
Veeva Systems (VEEV) Benefited in Q4 From Strong Execution - Insider Monkey
Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know - MSN
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks - Yahoo Finance
Best Momentum Stocks to Buy for April 3rd - TradingView
Veeva Systems Inc. (NYSE:VEEV) Receives $256.52 Average PT from Brokerages - MarketBeat
Veeva Systems SVP sells shares worth $178,019 - Investing.com Australia
Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It? - MSN
Veeva Systems SVP sells shares worth $178,019 By Investing.com - Investing.com Canada
We Think Veeva Systems' (NYSE:VEEV) Profit Is Only A Baseline For What They Can Achieve - Yahoo
VEEV Stock Slips Despite New Research Site Clinical Trial System - Yahoo Finance
Veeva Systems Inc (VEEV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.13%
1.91%
자본화:
|
볼륨(24시간):